Quantitative RT-PCR of Wilms tumor gene transcripts (WT1) for the molecular monitoring of patients with accelerated phase bcr/abl + CML

Leukemia Research

Volumn 29, Issue 3, 2005, Pages 343-345

  Na, Il Kang ^a   Kreuzer, Karl Anton ^a   Lupberger, Joachim ^a   Dörken, Bernd ^a   Le Coutre, Philipp ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Accelerated phase; CML; Imatinib; Quantitative RT PCR; Wilms tumor gene 1 (WT1)

Indexed keywords

BCR ABL PROTEIN; IMATINIB; MESSENGER RNA; WT1 PROTEIN;

ARTICLE; CANCER RELAPSE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; NEPHROBLASTOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; PIPERAZINES; PROGNOSIS; PYRIMIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; WT1 PROTEINS;

EID: 12344262623     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.08.003     Document Type: Article

References (5)

1. J. Moravcová, V. Zmekova, H. Klamova, J. Voglova, E. Faber, and K. Michalova Differences and similarities in kinetics of BCR-ABL transcripts levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase Leuk Res 28 2004 415 419
2. H. Tamaki, H. Ogawa, K. Inoue, T. Soma, T. Yamagami, and S. Miyake Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia Blood 88 1996 4396 4398
3. K.-A. Kreuzer, A. Saborowski, J. Lupberger, C. Appelt, I.K. Na, and P. le Coutre Fluorescent 5′-exonuclease assay for the absolute quantification of Wilms′ tumor gene (WT1) mRNA: implications of monitoring human leukaemias Br J Haematol 114 2 2001 313 318
4. M. Talpaz, R.T. Silver, B.J. Druker, J.M. Goldmann, C. Gambacorti-Passerini, and F. Guilhot Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study Blood 99 2002 1928 1937
5. U. Maurer, J. Brieger, E. Weidmann, P.S. Mitrou, D. Hoelzer, and L. Bergmann The Wilms′ tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro Exp Hematol 25 1997 945 950